Literature DB >> 10769682

3,5-diacetyl-1,4-dihydropyridines: synthesis and MDR reversal in tumor cells.

A Shah1, H Gaveriya, N Motohashi, M Kawase, S Saito, H Sakagami, K Satoh, Y Tada, A Solymosi, K Walfard, J Molnar.   

Abstract

Eleven 4-phenyl-3,5-diacetyl-1,4-dihydropyridines (AcDHPs) [G1-11] substituted at the phenyl ring were synthesized and compared for their cytotoxic activity and multidrug resistance (MDR)-reversing activity in in vitro assay systems. Among them, compound [G7] showed the highest cytotoxic activity against human promyelocytic leukemia HL-60 and human squamous cell carcinoma HSC-2 cells. However, no compounds tested produced radicals at pH 7.4-12.5. The activity of P-glycoprotein (Pgp) responsible for MDR in tumor cells was reduced by compounds [G2, 3, 6, 5, 8, 1, 11], verapamil [VP] and nifedipine [NP]. However, compounds [G4, 7, 10] were hardly active while G9 did not show a MDR reversing effect at 2.0-20.0 micrograms/mL. These data show a relationship between chemical structures and MDR-reversing effect on tumor cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10769682

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  3,5-Dibenzoyl-4-(3-phenoxyphenyl)-1,4-dihydro-2,6-dimethylpyridine (DP7) as a new multidrug resistance reverting agent devoid of effects on vascular smooth muscle contractility.

Authors:  Simona Saponara; Masami Kawase; Anamik Shah; Noboru Motohashi; Joseph Molnar; Katalin Ugocsai; Giampietro Sgaragli; Fabio Fusi
Journal:  Br J Pharmacol       Date:  2004-01-12       Impact factor: 8.739

2.  Diisopropyl 1-(4-meth-oxy-phen-yl)-2,6-dimethyl-4-(3-nitro-phen-yl)-1,4-dihydro-pyridine-3,5-dicarboxyl-ate.

Authors:  Kamini Kapoor; Vivek K Gupta; Rajni Kant; Milind P Pawar; Hitendra S Joshi
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-10-22

3.  ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal.

Authors:  Cheol-Hee Choi
Journal:  Cancer Cell Int       Date:  2005-10-04       Impact factor: 5.722

4.  Synthesis of novel 1,8-acridinediones derivatives: Investigation of MDR reversibility on breast cancer cell lines T47D and tamoxifen-resistant T47D.

Authors:  S A Moallem; N Dehghani; S Mehri; Sh Shahsavand; M Alibolandi; F Hadizadeh
Journal:  Res Pharm Sci       Date:  2015 May-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.